Locally Advanced Urothelial Cancer

DrugDrug NameDrug Description
DB13007Enfortumab vedotinAn antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.
DrugDrug NamePhaseStatusCount
DB15766Retifanlimab2Completed1
DB17391Trastuzumab vedotin2Recruiting1